Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized comparison of cladribine alone or in combination with cyclophosphamide, and cyclophosphamide, vincristine and prednisone in previously untreated low-grade B-cell non-Hodgkin lymphoma patients: final report of the Polish Lymphoma Research Group.
Kalinka-Warzocha E, Wajs J, Lech-Maranda E, Ceglarek B, Holowiecki J, Federowicz I, Walewski J, Czyz J, Robak T, Warzocha K; Polish Lymphoma Research Group. Kalinka-Warzocha E, et al. Among authors: czyz j. Cancer. 2008 Jul 15;113(2):367-75. doi: 10.1002/cncr.23558. Cancer. 2008. PMID: 18470902 Free article. Clinical Trial.
Rituximab (Mabthera, Rituxan) in patients with recurrent indolent lymphoma: evaluation of safety and efficacy in a multicenter study.
Walewski J, Kraszewska E, Mioduszewska O, Romejko-Jarosińska J, Hellmann A, Czyz J, Hołowiecki J, Kopera M, Grosicki S, Komarnicki M, Rumianowski L, Kuliczkowski K, Wróbel T, Dwilewicz-Trojaczek J, Robak T, Warzocha K, Załuski J, Wójcik E, Dmoszyńska A, Walter-Croneck A; Polish Lymphoma Research Group. Walewski J, et al. Among authors: czyz j. Med Oncol. 2001;18(2):141-8. doi: 10.1385/mo:18:2:141. Med Oncol. 2001. PMID: 11778760 Clinical Trial.
High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease. Retrospective study of the Polish Lymphoma Research Group.
Czyz J, Hellmann A, Dziadziuszko R, Hansz J, Goździk J, Hołowiecki J, Stella-Hołowiecka B, Kachel Ł, Knopińska-Posłuszny W, Nagler A, Meder J, Walewski J, Lampka E, Sułek K, Sawicki W, Lange A, Forgacz K, Suchnicki K, Pacuszko T, Skotnicki A, Mensah P, Jurczak W, Kuliczkowski K, Wróbel T, Mazur G, Dmoszyńska A, Wach M, Robak T, Warzocha K. Czyz J, et al. Bone Marrow Transplant. 2002 Jul;30(1):29-34. doi: 10.1038/sj.bmt.1703590. Bone Marrow Transplant. 2002. PMID: 12105774
Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: a study of 341 patients.
Czyz J, Dziadziuszko R, Knopinska-Postuszuy W, Hellmann A, Kachel L, Holowiecki J, Gozdzik J, Hansz J, Avigdor A, Nagler A, Osowiecki M, Walewski J, Mensah P, Jurczak W, Skotnicki A, Sedzimirska M, Lange A, Sawicki W, Sulek K, Wach M, Dmoszynska A, Kus A, Robak T, Warzocha K. Czyz J, et al. Ann Oncol. 2004 Aug;15(8):1222-30. doi: 10.1093/annonc/mdh304. Ann Oncol. 2004. PMID: 15277262 Free article.
[Autologous hematopoietic stem cell transplantation for the treatment of aggressive non-Hodgkin's lymphoma. The experience of Polish lymphoma research group].
Hołowiecki J, Giebel S, Walewski J, Krawczyk-Kuliś M, Hellmann A, Skotnicki A, Dmoszyńska A, Romejko J, Czyz J, Jurczak W, Kachel Ł, Wojnar J, Stella-Hołowiecka B, Saduś-Wojciechowska M, Sułek K, Jedrzejczak W, Robak T, Mariańska B, Szczylik C, Warzocha K. Hołowiecki J, et al. Among authors: czyz j. Pol Arch Med Wewn. 2003 Aug;110(2):863-8. Pol Arch Med Wewn. 2003. PMID: 14682225 Clinical Trial. Polish.
Treatment for primary refractory Hodgkin's disease: a comparison of high-dose chemotherapy followed by ASCT with conventional therapy.
Czyz J, Szydlo R, Knopinska-Posluszny W, Hellmann A, Gozdzik J, Hansz J, Smolewski P, Robak T, Osowiecki M, Walewski J, Avigdor A, Nagler A, Zemelka T, Pawlicki M, Sawicki Z, Wojtukiewicz M, Kachel L, Holowiecki J, Charlinski G, Jedrzejczak WW. Czyz J, et al. Bone Marrow Transplant. 2004 Jun;33(12):1225-9. doi: 10.1038/sj.bmt.1704508. Bone Marrow Transplant. 2004. PMID: 15094747
Two autologous transplants in the treatment of patients with Hodgkin's lymphoma: analysis of prognostic factors and comparison with a single procedure.
Czyz J, Dziadziuszko R, Knopinska-Posłuszny W, Hellmann A, Kachel L, Hołowiecki J, Czyz A, Komarnicki M, Osowiecki M, Walewski J, Jurczak W, Skotnicki A; Polish Lymphoma Research Group. Czyz J, et al. Among authors: czyz a. Leuk Lymphoma. 2007 Mar;48(3):535-41. doi: 10.1080/10428190601158621. Leuk Lymphoma. 2007. PMID: 17454595
Comparable Efficacy of Idelalisib Plus Rituximab and Ibrutinib in Relapsed/refractory Chronic Lymphocytic Leukemia: A Retrospective Case Matched Study of the Polish Adult Leukemia Group (PALG).
Puła B, Budziszewska BK, Rybka J, Gil L, Subocz E, Długosz-Danecka M, Zawirska D, Waszczuk-Gajda A, Iskierka-Jażdżewska E, Kopacz A, Szymczyk A, Czyż J, Lech-Marańda E, Warzocha K, Jamroziak K. Puła B, et al. Among authors: czyz j. Anticancer Res. 2018 May;38(5):3025-3030. doi: 10.21873/anticanres.12557. Anticancer Res. 2018. PMID: 29715135
133 results